GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » Cyclically Adjusted PS Ratio

Nippon Shinyaku Co (Nippon Shinyaku Co) Cyclically Adjusted PS Ratio : 1.65 (As of Jun. 01, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co Cyclically Adjusted PS Ratio?

As of today (2024-06-01), Nippon Shinyaku Co's current share price is $5.1545. Nippon Shinyaku Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $3.13. Nippon Shinyaku Co's Cyclically Adjusted PS Ratio for today is 1.65.

The historical rank and industry rank for Nippon Shinyaku Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

NPPNY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.94   Med: 5.63   Max: 7.65
Current: 1.94

During the past years, Nippon Shinyaku Co's highest Cyclically Adjusted PS Ratio was 7.65. The lowest was 1.94. And the median was 5.63.

NPPNY's Cyclically Adjusted PS Ratio is ranked better than
53.76% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.085 vs NPPNY: 1.94

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Nippon Shinyaku Co's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.880. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $3.13 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nippon Shinyaku Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Nippon Shinyaku Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co Cyclically Adjusted PS Ratio Chart

Nippon Shinyaku Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.37 5.85 5.46 3.48 2.46

Nippon Shinyaku Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.48 3.43 3.61 2.79 2.46

Competitive Comparison of Nippon Shinyaku Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's Cyclically Adjusted PS Ratio falls into.



Nippon Shinyaku Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Nippon Shinyaku Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5.1545/3.13
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nippon Shinyaku Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Nippon Shinyaku Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.88/107.2000*107.2000
=0.880

Current CPI (Mar. 2024) = 107.2000.

Nippon Shinyaku Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.652 98.000 0.713
201409 0.640 98.500 0.697
201412 0.690 97.900 0.756
201503 0.656 97.900 0.718
201506 0.578 98.400 0.630
201509 0.622 98.500 0.677
201512 0.734 98.100 0.802
201603 0.682 97.900 0.747
201606 0.836 98.100 0.914
201609 0.757 98.000 0.828
201612 1.016 98.400 1.107
201703 0.740 98.100 0.809
201706 0.810 98.500 0.882
201709 0.853 98.800 0.926
201712 0.921 99.400 0.993
201803 0.831 99.200 0.898
201806 0.937 99.200 1.013
201809 0.851 99.900 0.913
201812 1.109 99.700 1.192
201903 0.925 99.700 0.995
201906 1.009 99.800 1.084
201909 0.966 100.100 1.035
201912 1.045 100.500 1.115
202003 0.983 100.300 1.051
202006 1.032 99.900 1.107
202009 0.981 99.900 1.053
202012 1.217 99.300 1.314
202103 1.025 99.900 1.100
202106 1.381 99.500 1.488
202109 1.030 100.100 1.103
202112 1.133 100.100 1.213
202203 0.976 101.100 1.035
202206 0.987 101.800 1.039
202209 0.920 103.100 0.957
202212 1.067 104.100 1.099
202303 0.951 104.400 0.977
202306 0.972 105.200 0.990
202309 0.911 106.200 0.920
202312 1.016 106.800 1.020
202403 0.880 107.200 0.880

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nippon Shinyaku Co  (OTCPK:NPPNY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Nippon Shinyaku Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co (Nippon Shinyaku Co) Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (Nippon Shinyaku Co) Headlines

No Headlines